Statement from ALPS on risks of interventions for Peripheral Artery Disease (PAD)

15. July 2023
ALPS

Recent media reports (see links below) have highlighted serious concerns about the dangers of overuse or misuse of procedures to treat PAD. PAD is a common condition, often causing no or only mild, non-disabling symptoms, but when severe it can lead to major amputation. ALPS is dedicated to promoting the creation and support of multidisciplinary teams to reduce the burden of preventable limb amputations through patient-centric, evidence-based care.

Amputation prevention hinges on early and accurate diagnosis, along with the optimal use of a full range of therapies targeted to the patient’s risk, goals, and stage of disease. Inappropriate and overuse of invasive treatments for PAD can lead to an acceleration of the disease process, a high frequency of repeat procedures, and the potential for deterioration. Patients with risk factors such as diabetes are at the highest risk. Patients and their families should be educated about the signs and symptoms of PAD, receive appropriate medical therapies, lifestyle advice (e.g. smoking cessation, diet and exercise) and surveillance. They must also be fully informed when decision-making about invasive treatments. While this public spotlight on inappropriate treatment is important, published data show that it represents a small minority of vascular specialists. We hope that it will not deter patients who are at risk from seeking timely evaluation that is critical to avoid limb loss.

 

Links:

New York Times: Profiting From Risky Atherectomies That Can Lead To Amputations 

ProPublica:  A CMS Effort To Save Money Enriched Doctors At Patients’ Cost

ProPublica: Artierial Motives – The Big Business Of Clogged Arteries

 

For further details, please contact Alison Evans, ALPS Communication & Marketing Coordinator at alison@alpslimb.org.

About ALPS

We at ALPS have made it our vision to eliminate preventable amputations over the next generation. We believe this can be achieved by promoting interdisciplinary teams to advance the science, clinical care, advocacy, awareness, and education of limb preservation through increased access to resources and specialized care that improves patient-centered outcomes.

 

About ALPS Board of Directors

For more information about ALPS Board of Directors click here.

 

Related Articles

Honoring the Legacy of Rep. Donald M. Payne Jr.: Advocate for Healthcare and Limb Preservation

Rep. Donald M. Payne Jr.’s remarkable life and enduring legacy as a healthcare advocate and limb preservation champion are remembered. His dedication to expanding access to high-quality, affordable care and raising awareness of peripheral artery disease (PAD) continues to impact countless lives. Learn more about his significant contributions and how his work will inspire future generations.

read more

The Future of DFU Management: Study Reveals Interdisciplinary Power in Diabetic Foot Ulcer Care

Discover the transformative impact of interdisciplinary teams in diabetic foot ulcer (DFU) care. This article explores a recent study showcasing how an Interdisciplinary Limb Preservation Service (LPS) significantly reduces major amputation rates and hospital stays. Learn how diverse specialties working together lead to optimal patient outcomes and healthcare cost savings.

read more

American Limb Preservation Society Expands Leadership Team with Appointment of Two Esteemed Board Members to Drive Innovation in Limb Preservation

The American Limb Preservation Society (ALPS) proudly announces the appointment of two distinguished professionals to its esteemed board of directors. Dr. Cy Dove, DPM, and Dr. Katharine L. McGinigle, MD, MPH, bring a wealth of experience and expertise to advance ALPS mission of promoting limb preservation efforts worldwide.

read more